| Active substance |
GHRP |
| Also known as |
Pralmorelin, GHRP-2 |
| Blood pressure |
Can cause transient increases in blood pressure |
| Category |
Peptides |
| Chemical name |
Growth Hormone Releasing Peptide-2 |
| Dosage |
2 Mg |
| Dosage (medical) |
Typically 100-300 mcg per injection, administered 2-3 times daily |
| Dosage (sports) |
100-300 mcg per injection, administered 2-3 times daily |
| Dosage Unit |
Ml |
| ean13 |
1392806356603 |
| Effects |
Increased growth hormone levels, enhanced muscle growth, reduced body fat, improved recovery |
| FORM |
Injection |
| Formula |
C45H55N9O6 |
| Half-life |
Approximately 30 minutes |
| Hepatotoxicity |
No |
| Lab Test |
Growth Hormone levels |
| Main action |
Stimulates the secretion of growth hormone |
| Milliliter Size |
4 Ml |
| Reference |
SMCTRO39 |
| Side effects |
Water retention, hunger sensations, tingling or numbness, high blood sugar levels, decreased insulin sensitivity |
| Storage conditions |
Store in a cool, dry place away from light, usually refrigerated |
| Substance class |
Peptide |
| Trade name |
Pralmorelin |
| Use in sports |
Commonly used for muscle growth, recovery enhancement, and improved performance |
| Water Retention |
Yes |
| Packing |
Vial |
